UltraClear AS-BK-00055Recalls & reported problems
Acclaro Corporation · Fractional Mid IR Fiber Laser System (Black) · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00850039149023), received between Feb 19, 2026 and Feb 19, 2026 — classified as 1 injury.
The most frequently reported specific device problem is “Improper or Incorrect Procedure or Method” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Improper or Incorrect Procedure or Method1
Patient problems
- Skin Infection1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryFeb 19, 2026Improper or Incorrect Procedure or Method
PATIENT WAS REPORTED AS HAVING LESIONS ON FACE THAT DEVELOPED AFTER ULTRACLEAR TREATMENT. PHOTOGRAPHS PROVIDED OF THE FIRST 11 DAYS POST TREATMENT SHOWED REDNESS AND CRUSTING THROUGH THE FIRST 5 DAYS DEVELOPING INTO OPEN LESIONS BY DAY 11. THE TREATING PHYSICIAN PRESCRIBED HYPOCHLOROUS ACID SPRAY ON DAY 5 TO REDUCE REDNESS AND INFLAMMATION. ON DAY 9 THE PATIENT WAS PRESCRIBED KEFLEX (CEPHALEXIN, AN ANTIBIOTIC) AS BACTERIAL INFECTION WAS SUSPECTED. MEMBERS OF ACCLARO'S MEDICAL ADVISORY BOARD (MAB) REVIEWED THE PROVIDED PHOTOGRAPHS. THE MAB STATED THAT HAD THESE SYMPTOMS PRESENTED IN CLINIC THEY WOULD HAVE PRESCRIBED 1000MG OF VALTREX 3X PER DAY AND CULTURE THE LESIONS AS SOON AS AN OUTBREAK OCCURRED. MAB STATED THEY WOULD PRESCRIBE KEFLEX OR A SIMILAR ANTIBIOTIC AND IF THE CULTURE RESULTS INDICATED MRSA, THEY WOULD PRESCRIBE DOXYCYCLINE OR TETRACYCLINE. THIS INFORMATION WAS COMMUNICATED WITH THE REPORTING CLINIC. THE CLINIC STATED THEY DID NOT PRESCRIBE VALTREX AS THERE WAS NO HISTORY OF HERPES IN THE PATIENT, SO THEY PRESCRIBED KEFLEX. THE CLINIC CULTURED THE LESIONS AND THE RESULTS INDICATED MRSA. THE PATIENT WAS THEN PRESCRIBED VALTREX AND TETRACYCLINE. IT IS THE OPINION OF ACCLA
Patient problems: Skin Infection
MAUDE report 24388419 ↗
Other Powered Laser Surgical Instrument devices
- Moxy 0010-2400Boston Scientific Corporation · Powered Laser Surgical Instrument4,572 reports
- SOLTIVE TFL-PLSGyrus ACMI, LLC · Powered laser surgical instrument6 recalls450 reports
- Flexiva TracTip M0068403960Boston Scientific Corporation · Powered laser surgical instrument562 reports
- Moses™ AC-10030100Lumenis Ltd. · Powered Laser Surgical Instrument532 reports
- Flexiva M0068403910Boston Scientific Corporation · Powered laser surgical instrument376 reports
- Visualase 9735542Medtronic Navigation, Inc. · Powered laser surgical instrument1 recall2 deaths311 reports
- SOLTIVE TFL-SLSGyrus ACMI, LLC · Powered laser surgical instrument6 recalls33 reports
- NeuroBlate® System 20980Monteris Medical Inc · Powered laser surgical instrument7 deaths296 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page